
|Slideshows|October 9, 2018
- Managed Healthcare Executive November 2018 Issue
- Volume 28
- Issue 11
Eight Top Oncology Drug Approvals
Author(s)Erin Johanek, PharmD, RPh
New cancer drugs continue to offer patients hope. Here are eight of them.
Advertisement
Articles in this issue
almost 8 years ago
Looser Restrictions on HRAs on the Horizonalmost 8 years ago
Nine Ways to Deal with Escalating Drug Costsalmost 8 years ago
Time to Address ‘Financial Toxicity’ of Cancer Treatmentalmost 8 years ago
CAR T-cell Therapy: How Payers are Responding to Huge Price Tagsalmost 8 years ago
Medical Foods Strive for Insurance Coveragealmost 8 years ago
New Chiefs at MCOs: 4 Positions You May Want to Addalmost 8 years ago
Eight Predictions for Cancer Care in 10 Yearsabout 8 years ago
Is Precision Medicine Worth the Hype? Oncologists Weigh InAdvertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
Biosimilars provide modest cost savings for cancer patients, study finds
3
On Medicaid work requirements, the end of ACA enhanced subsidies and ACAP’s 25th anniversary
4
USPS Woes Continue: Health Plans, Be Prepared
5

























